{
  "query": "hazard ratio nonfatal failure",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT05699915",
          "briefTitle": "Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Immune-related Adverse Event", "Cardiac Abnormalities, Variable", "Immune Checkpoint Inhibitor-Related Myocarditis", "Diastolic Dysfunction", "Atherosclerosis", "Cardiotoxicity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 105,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04329624",
          "briefTitle": "Effect Levosimendan Administration on Postoperative NT-proBNP in Cardiac Risk Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cardiovascular Risk Factor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years",
          "maximumAge": "85 Years"
        }
      }
    ]
  }
}
